Table 1.
Demographic details from the included studies
| Study | Year | Study design | Level of evidence | Patients treated | Patients at followup | Followup rate (%) | Followup after revision ACL-R (years) | Mean age at revision ACL-R (years) | Mean time from 1° ACL-R to Revision ACL (months) |
|---|---|---|---|---|---|---|---|---|---|
| O’Neill [22] | 2004 | Prospective | IV | 50 | 48 28 M/20 F |
96% | 7.5 (2–13) |
33 (13–57) |
60 (7–276) |
| Grossman et al. [12] | 2005 | Retrospective | IV | 35 | 29 22 M/7 F |
83% | 5.6 | 30.2 | 56 (9–192) |
| Thomas et al. [27] | 2005 | Prospective | III | 49 | 49 37 M/12 F |
100% | 6.2 (3–11) |
35.4 | NA |
| Ferretti et al. [7] | 2006 | Retrospective | IV | 30 | 30 | 100% | 5.0 (2–8) |
34 (21–39) |
60 (12–132) |
| Lidén et al. [16] | 2006 | Retrospective | IV | 14 | 12 | 86% | 9.6 (8.5–10.6) |
28 (23–39) |
64 (15–132) |
| Salmon et al. [23] | 2006 | Prospective | IV | 57 | 50 | 88% | 7.4 (5.0–9.1) |
27 (15–39) |
36 (2–132) |
| Battaglia et al. [3] | 2007 | Retrospective | IV | 95 | 63 36 M/27 F |
66% | 6.1 (3.0–13.2) |
31 (18–60) |
61 (3–316) |
| Diamantopoulos et al. [6] | 2008 | Retrospective | IV | 148 | 107 64 M/43 F |
72% | 6.0 ± 1.7 | 39 ± 9 | 60 ± 54 |
| Ahn et al. [2] | 2011 | Retrospective | IV | 50 | 41 | 82% | 6.3 (3.5–9.8) |
32 (21–55) |
59 (6–216) |
| Lind et al. [17] | 2012 | Retrospective | IV | 168 | 128 64 M/64 F |
76% | 5.9 (2.0–9.0) |
31 | 58 (0–311) |
| Mayr et al. [19] | 2012 | Retrospective | III | 17 (autografts) | 15 9 M/6 F |
88% | 5.7 ± 0.6 | 30 ± 9 | NA |
| 17 (allografts) | 14 | 82% | 5.8 ± 0.5 | 35 ± 13 | NA | ||||
| Franceschi et al. [8] | 2013 | Retrospective | IV | 30 | 30 19 M/11 F |
100% | 6.8 (5–9) |
29.1 (19–42) |
34 |
| Gifstad et al. [9] | 2013 | Retrospective | III | 69 | 56 25 M/31 F |
81% | 7.5 (2.8–13.2) |
26.5 | 38 (5–117) |
| Kievit et al. [14] | 2013 | Retrospective | III | 30 | 25 18 M/7 F |
86% | 5.3 (2.3–12.2) |
34.6 | NA |
| Chougule et al. [4] | 2015 | Retrospective | IV | 20 | 20 14 M/6 F |
100% | 6.0 | 33.7 | NA |
Values are mean ± SD or numbers with ranges in parentheses; ACL-R = anterior cruciate ligament reconstruction; ACL = anterior cruciate ligament; M = male; F = female; NA = not applicable.